PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23378325-8	2013	In the IM IFNbeta-1a group, persistent disease activity predicted severe EDSS worsening: gadolinium-enhancing lesions (odds ratio [OR], 8.96; p < 0.001); relapses (OR, 4.44; p = 0.010); and new T2 lesions (OR, 2.90; p = 0.080).	Gadolinium	89-99	interferon beta 1	Homo sapiens	10-17	
23378325-11	2013	Particular attention should be paid to gadolinium-enhancing lesions on IFNbeta therapy, as their presence strongly correlates with severe disability 15 years later.	Gadolinium	39-49	interferon beta 1	Homo sapiens	71-78